Skip to content

RA Capital Management portfolio · Q2 2026

RA Capital Management, L.P. · CIK 0001346824 ·13F filings on SEC EDGAR

In Q2 2026, RA Capital Management, L.P. reported 84 positions worth $11.5B. Its largest holding was ASND at 23.8% of the portfolio, and the top 10 made up 60%. Its largest new position was ASND ($2.7B), and it sold out of 04351P101.

Portfolio value
$11.5B
Positions
84
Top 10 share
60.4%
Changes vs Mar 31, 2026
  • NEW 17
  • ADD 10
  • REDUCE 10
  • EXIT 18

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 44 positions are grouped as one box.

Portfolio history

Q4 2025 to Q2 2026, 3 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

ASCENDIS PHARMA A/SASNDCDTXRYTMPCVXPBLSRNAMOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Mar 31, 2016, when our collected history starts, so the average starts from that quarter's price.

Changes in shares

Change in shares held vs Mar 31, 2026, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Mar 31, 2026 and not reported for Q2 2026.

StockPrior weightPrior sharesPrior valueChange
04351P101
ASCENDIS PHARMA A/S
24.92%10,281,496$2.4BEXIT
DNTH
DIANTHUS THERAPEUTICS INC
2.32%2,611,733$219.2MEXIT
PRAX
PRAXIS PRECISION MEDICINES I
1.28%373,787$120.4MEXIT
SRPT
SAREPTA THERAPEUTICS INC
0.90%3,902,596$84.9MEXIT
SYRE
SPYRE THERAPEUTICS INC
0.87%1,621,620$81.8MEXIT
FULC
FULCRUM THERAPEUTICS INC
0.49%6,053,960$46.4MEXIT
OLMA
OLEMA PHARMACEUTICALS INC
0.41%2,600,000$38.8MEXIT
DSGN
DESIGN THERAPEUTICS INC
0.34%2,972,973$31.6MEXIT
TVTX
TRAVERE THERAPEUTICS INC
0.24%746,841$22.2MEXIT
GRAL
GRAIL INC
0.23%428,266$22.1MEXIT
RLMD
RELMADA THERAPEUTICS INC
0.22%2,947,369$20.5MEXIT
STRO
SUTRO BIOPHARMA INC
0.19%715,307$17.8MEXIT
CTNM
CONTINEUM THERAPEUTICS INC-A
0.18%1,296,012$16.9MEXIT
INSP
INSPIRE MEDICAL SYSTEMS INC
0.18%325,663$16.8MEXIT
HNGE
HINGE HEALTH INC-A
0.15%364,613$14.1MEXIT
WGS
GENEDX HOLDINGS CORP
0.14%209,887$13.5MEXIT
RNA
ATRIUM THERAPEUTICS INC
0.12%864,102$11.6MEXIT
MPLT
MAPLIGHT THERAPEUTICS INC
0.05%248,294$5MEXIT

SEC filings for Q2 2026